SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-039151
Filing Date
2023-11-02
Accepted
2023-11-02 16:29:05
Documents
2
Period of Report
2023-11-02

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 437428
2 formdef14a_001.jpg GRAPHIC 129107
  Complete submission text file 0001493152-23-039151.txt   616646
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12555 | Film No.: 231372841
SIC: 2834 Pharmaceutical Preparations